Skip to main content
Fig. 2 | Trials

Fig. 2

From: Implementation of an evidence-based management algorithm for patients with chronic pancreatitis (COMBO trial): study protocol for a stepped-wedge cluster-randomized controlled trial

Fig. 2

Stepped-wedge design with 6 cluster groups. No cluster groups receive the intervention at baseline (6 months); all cluster groups start with continuing current practice. Cluster groups are randomly assigned to unidirectional cross-over to receive the intervention at 2-month intervals. Total trial duration will be a maximum of 35 months; a baseline period of 6 months, a current practice period of varying in length, a transition period of 1 month, an intervention period of 12 months, and a follow-up period with a minimum duration of 6 months for those patients participating in the per-protocol analysis

Back to article page

Trials

ISSN: 1745-6215